Cargando…
PD-1 and PD-L1 Expression on Circulating Lymphocytes as a Marker of Epstein-Barr Virus Reactivation-Associated Proliferative Glomerulonephritis
Alterations to the programmed cell death protein-1 (PD-1) pathway were previously shown to be involved in a poorer prognosis for patients with proliferative glomerulonephritis (PGN). Here, we investigated the association between several infectious agents and the expression of PD-1 and its ligand (PD...
Autores principales: | Grywalska, Ewelina, Smarz-Widelska, Iwona, Korona-Głowniak, Izabela, Mertowski, Sebastian, Gosik, Krzysztof, Hymos, Anna, Ludian, Jarosław, Niedźwiedzka-Rystwej, Paulina, Roliński, Jacek, Załuska, Wojciech |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7663145/ https://www.ncbi.nlm.nih.gov/pubmed/33121190 http://dx.doi.org/10.3390/ijms21218001 |
Ejemplares similares
-
The Importance of Toll-like Receptor 9 Expression on Monocytes and Dendritic Cells in the Context of Epstein–Barr Virus Infection in the Immunopathogenesis of Primary Glomerulonephritis
por: Smarz-Widelska, Iwona, et al.
Publicado: (2022) -
TLR2 Expression on Select Lymphocyte Subsets as a New Marker in Glomerulonephritis
por: Mertowski, Sebastian, et al.
Publicado: (2020) -
The PD-1/PD-L1 Inhibitory Pathway is Altered in Primary Glomerulonephritides
por: Grywalska, Ewelina, et al.
Publicado: (2017) -
Pathophysiology and Clinical Manifestations of COVID-19-Related Acute Kidney Injury—The Current State of Knowledge and Future Perspectives
por: Smarz-Widelska, Iwona, et al.
Publicado: (2021) -
The Clinical, Pathological, and Prognostic Value of High PD-1 Expression and the Presence of Epstein–Barr Virus Reactivation in Patients with Laryngeal Cancer
por: Klatka, Janusz, et al.
Publicado: (2022)